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Background: Fast-track (FT) programmes represent a series of multimodal concepts that may reduce
surgical stress and speed up convalescence after surgery. The aim of this systematic review was to
evaluate FT programmes for patients undergoing hepatopancreatic surgery.
Methods: PubMed, Embase and the Cochrane Library databases were searched for studies of FT vs.
conventional recovery strategies for liver and pancreatic resections.
Results: For liver surgery, three cohort studies were included. Primary hospital stay was significantly
reduced after FT care in two of the three studies. There were no significant differences in rates of
readmission, morbidity and mortality. For pancreatic surgery, three cohort studies and one case-control
study were included. Primary hospital stay was significantly shorter after FT care in three out of the four
studies. One study reported a significantly decreased readmission rate (7% vs. 25%; P = 0.027), and
another study showed lower morbidity (47.2% vs. 58.7%; P < 0.01) in favour of the FT group. There was
no difference in mortality between the FT and control groups.
Conclusions: FT rehabilitation for liver and pancreatic surgical patients is feasible. Future investigation
should focus on optimizing individual elements of the FT programme within the context of liver and
pancreatic surgery.
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Introduction
‘Enhanced recovery’ or ‘fast-track’ (FT) programmes are struc-
tured interdisciplinary strategies that have been introduced to
optimize peri-operative care and accelerate post-operative recov-
ery. The main aim of the FT protocol is to reduce the metabolic
and inflammatory response to surgical stress and preserve vital
functions.1 First developed by Kehlet et al,2–4 these protocols pres-
ently include key elements such as pre-operative counselling, the
limited use of drains and nasogastric tubes, optimal pain relief,
early nutrition and enhanced patient mobilization.5 Apart from
elective colorectal surgery, FT programmes have been proposed in
other surgical fields, such as gastro-oesophageal,6 musculoskel-
etal7 and aortic8 surgery. To date, however, the principles of
enhanced recovery have rarely been applied to liver and pancreatic
surgery.9,10
Hepatopancreatic resections represent major abdominal opera-
tions with high risks, carried out with increasing frequency, and
most often for malignant conditions.11–13 Nonetheless, both mor-
bidity and mortality associated with these procedures have
decreased over the years.12,14 The aim of this systematic review was
to assess the evidence for FT peri-operative care in patients under-
going hepatopancreatic resections.
Methods
Search strategy
Pubmed, Embase and the Cochrane Library databases were
searched on 31 May 2011 by the first author, using the following
search string for titles and abstracts: [(‘fast track’ OR ‘enhanced
recovery’ OR ‘eras’ OR ‘early discharge’ OR ‘clinical pathways’ OR
‘clinical pathway’ OR ‘critical pathways’ OR ‘critical pathway’)
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AND (‘liver’ OR ‘hepatic’ OR ‘hepatectomy’ OR ‘pancreas’ OR
‘pancreatic’ OR ‘pancreatectomy’ OR ‘pancreaticoduodenectomy’
OR ‘whipple’)]. Titles and abstracts were reviewed and relevant
papers identified. Reference lists of retrieved articles were used to
complete the search.
Inclusion and exclusion criteria
Studies were included if they fulfilled all of the following criteria:
(i) adult patients undergoing elective liver or pancreatic resection
for benign or malignant disease, (ii) comparison of a FT multi-
modal strategy with conventional care, (iii) reporting at least four
FT items and (iv) reporting at least one of the following outcome
measures: length of stay, readmission, morbidity and mortality.
Trials investigating transplantation were excluded. Only clinical
studies published in English, German or French were included. No
unpublished data or conference abstracts were included. If studies
proved to have an overlap in patient population, only the largest
publication was included. To date, there are 20 recognized proto-
col elements that make up the FT programme.5 In this review, a
total of 18 FT items were scored, as two items, i.e. writing an audit
(applicable to all included studies) and the use of suprapubic
catheters for pelvic surgery, were considered not relevant.
Outcomes of interest
Primary outcome parameters were length of hospital stay, read-
mission rate, morbidity and mortality. Secondary outcomes
included bowel function, cost-effectiveness and quality of life. The
level of evidence was rated according to the Oxford Centre for
Evidence-based Medicine Levels of Evidence.15
Results
A total of 518 publications were identified, of which 18 were
relevant. Five studies16–19,21 lacked a traditional care group
(control). Four studies20,22–24 were excluded because of failure to
apply a minimum of four FT elements, and one trial25 did not
describe details of the FT protocol. Furthermore, one study26 was
excluded because part of the data had been used in another pub-
lication. Finally, seven trials comparing FT peri-operative care
with traditional care were identified (Fig. 1).
Three articles described outcomes for patients who underwent
liver resection for primary or secondary tumours,10,27,28 whereas
four studies described patients who underwent pancreatic
surgery9,29–31 (Table 1). Included trials were published between
2006 and 2011. Median population size in the FT group was 61
(range 12–252) patients. All trials used a prospective intervention
group and a retrospective control group. They had evidence level
2b or 3b on the Oxford Level of Evidence scale.
Fast-track items
There was some clinical heterogeneity regarding specific FT inter-
ventions used in the studies. The number of included FT items
ranged from 5 to 18 with a median of 7. Post-operative nutritional
care and early mobilization were the commonest FT interven-
tions, whereas laparoscopic surgery and minimal incisions were
reported infrequently (Table 2).
Liver resection
Primary outcome measures were reported in all studies. Primary
hospital stay was significantly reduced after FT care in two out of
the three studies.10,27 In one study, median hospital stay was 6 days
in the FT group compared with 8 days in the control group (P <
0.001).10 In the other study, primary hospital stay was reduced
from 11 days to 7 days (P < 0.01).27 There were no significant
differences in rates of readmission, morbidity and mortality
between FT and control groups (Table 1).
Gastrointestinal function was reported in two studies.10,28 One
trial found a significantly shorter time to successful resumption of
a normal diet in the FT group (1 post-operative day for FT
patients vs. 3 days for the control group).10 In the only study that
reported on cost-effectiveness data, the mean charges per hospital
stay were Renminbi (RMB) 26 626 for the control group and RMB
21 004 for the FT group (P < 0.05).27
Pancreatic resection
All four studies reported on primary hospital stay and this was
significantly shorter after FT care in three out of the four stud-
ies.9,29,30 Readmission rates were reported in three studies. In one
study, the readmission rate was reduced in favour of the FT
patients (7% vs. 25%; P = 0.027).29 However, the effect on read-
mission must be interpreted with caution. The control group was
operated before the recruitment of a team focused on pancreatic
surgery. The team was encouraged to increase the case load but
were not given additional bed days. Furthermore, the surgical
volume increased from an average of 1.2 cases per month pre-FT
to 3.2 cases per month post-FT, as a result of, e.g. tertiary referrals.
Morbidity rates were reported in all studies. In one study, man-
agement within an FT pathway led to significantly fewer post-
operative complications (47.2% vs. 58.7%; P < 0.01).9 Mortality
was reported in three of the studies and was not significantly
different between the FT and control groups (Table 1).
Two studies assessed gastrointestinal function.9,31 In one study,
the FT group had earlier oral intake and first bowel movement
post-operatively as compared with the control group.31 In the
other study, patients undergoing a pancreaticoduodenectomy and
managed with a FT pathway had a reduced incidence of delayed
gastric emptying (13.9% vs. 24.6%; P = 0.004).9 The cost-
effectiveness of FT protocols was reported in two trials.29,30 In one
study, the mean total hospital charges were significantly decreased
for FT patients, from $240 242  $32 490 to $126 566  4883
(P  0.0001).30
Discussion
The principles of enhanced recovery have been proven to be safe
and effective in several surgical settings.7,8,32 This systematic review
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examined the evidence for FT protocols when compared with
standard care in elective liver and pancreatic surgery using data
from cohort and case-control studies as there are no randomized
control trials (RCTs) in this area. The results suggest that FT
programmes can enhance post-operative recovery and reduce the
length of hospital stay with no increase in adverse events, such as
readmissions, morbidity and mortality.
The length of hospital stay after hepatopancreatic surgery is
typically a minimum of 1 week. In liver surgery, the median
length of stay with traditional care pathways ranges from 7 to 11
days.12,33 For pancreatic resections, the hospital stay is between 9
and 15 days.11,13,34 Of the seven studies identified, all reported a
shorter hospital stay in FT patients. This difference was statisti-
cally significant in five of the studies,9,10,27,29,30 but failed to reach
statistical significance in two studies,28,31 perhaps as a result of
limited study populations. The use of hospital stay as a marker
for FT programme success may be inappropriate, as it has been
shown that functional recovery of patients undergoing FT
colonic35 and liver28 surgery is attained days before patient
discharge.
As none of the studies reported a difference in mortality and the
only significant difference in morbidity that was detected actually
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favoured FT surgery,10 one could at least argue that safety seemingly
is not impaired when using an enhanced recovery programme.
Nevertheless, a suggested disadvantage of FT surgery has been a
possibly higher readmission rate. Although there have been some
reports on FT programmes for colorectal surgery with increased
readmission rates noted,36–39 the total number of days in hospital,
when also including the added stay for readmissions, remained
lower when applying FT surgery.36–39 Furthermore, the available
studies on hepatopancreatic surgery have not reported an
increased readmission rate after FT recovery.9,10,27–31 It is also
Table 1 Characteristics of included studies
Study (year) Type of
surgery
Population
FT/C
Study
type
LOS
FT/C
Readmission
FT/C
Morbidity
FT/C
Mortality
FT/C
E
van Dam et al.
(2008)10
Liver 61/100 CS 6/8 (P < 0.001)
median
13%/10%
(P = 0.543)
41%/31%
(P = 0.197)
0%/2%
(P = 0.526)
2B
OL
Stoot et al.
(2009)28
Liver 13/13 CS 5/7 (P = 0.305)
median
0%/0% 15%/15%
(P = 1.0)
0%/0% 2B
LL
Lin et al. (2011)27 Liver 56/61 CS 7/11 (P < 0.01)
median
7.1%/3.3%
(P = 0.424)
46.4/44.3
(P = 0.814)
1.8/1.6
(P = 0.706)
2B
OL
Wichmann et al.
(2006)31
Pancreas 12/12 CCS 12.9/20 (NS)
mean
– 8.3%/8.3% – 3B
PR
Kennedy et al.
(2007)30
Pancreas 91/44 CS 7/13 (P < 0.0001)
median
7.7%/7.0%
(NS)
37%/44%
(NS)
1.1%/2.3%
(NS)
2B
PD
Balzano et al.
(2008)9
Pancreas 252/252 CS 13/15 (P < 0.001)
median
7.1%/6.3%
(P = 0.865)
47.2%/58.7%
(P < 0.01)
3.6 % vs. 2.8%
(P = 0.798)
2B
PD
Kennedy et al.
(2009)29
Pancreas 71/40 CS 6.7/10.2 (P <
0.037) mean
7%/25%
(P < 0.027)
15.7%/37.5%
(NS)
1.1%/2.3%
(NS)
2B
DP
OL, open liver resection; LL, laparoscopic liver resection; PD, pancreaticoduodenectomy; DP, distal pancreatectomy; PR, any pancreatic resection;
FT, fast-track; C, control; CS, cohort study; CCS, case-control study; LOS, length of hospital stay in days; E, level of evidence; NS, not significant;
–, not described.
Table 2 Number of fast-track items used in included studies
van Dam
et al.
(2008)10
Stoot
et al.
(2009)28
Lin
et al.
(2011)27
Wichmann
et al.
(2006)31
Kennedy
et al
(2007)30
Balzano
et al.
(2008)9
Kennedy
et al.
(2009)29
Preadmission counselling + + + + + +
No bowel preparation + + + +
Pre-operative fasting and pre-operative
carbohydrate loading
+ + + +
No pre-anaesthetic medication + + +
Thromboembolic prophylaxis + + + + + +
Prophylactic antibiotics + + + + + +
Epidural analgesia + + + + +
Prevention of post-operative nausea and vomiting + + +
Laparoscopic surgery +
Minimal incisions +
No standard nasogastric tubes post-operatively + + +
Prevention of intra-operative hypothermia + + +
Fluid restriction + + + + +
No surgical drains + + +
Prevention of post-operative ileus + +
No systemic opioids + + +
Post-operative nutritional care + + + + + + +
Early mobilization + + + + + + +
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important to consider that these protocols aim at an earlier recov-
ery, ideally applying a check list for discharge criteria, and thus
supposedly initiate patient discharge after adequate recovery and
not simply earlier than is done with ‘traditional’ care.
In addition to abovementioned primary outcomes, there were
also some promising results found in terms of secondary out-
comes. Four studies analysed the recovery of gastrointestinal func-
tion,9,10,28,31 three of them detecting a difference, and all in favour
of FT surgery.9,10,31 In terms of cost-effectiveness, three studies
reported an improvement with enhanced recovery pro-
grammes,27,29,30 although not significant in one study29. These are
additional data supporting the use of FT surgery.
None of the selected articles reported measurements of quality
of life. In colorectal surgery, no difference in quality of life after
surgery has been shown when comparing patients with FT and
conventional care.40,41 However, during the first weeks after
surgery, the quality of life deteriorates after colorectal,41 as well as
after liver surgery.42 It can be argued that a FT protocol also should
include measures to be carried out even when the patient has left
the hospital.43
The structure of this review meant that one important study of
FT peri-operative care had to be excluded because it did not
compare outcome data with traditional care. The previous study by
Hendry et al.18 is an RCT in liver resection that addressed the role of
oral nutritional supplements (ONS) and magnesium hydroxide
alone and in various combinations within a multimodal FT pro-
gramme. It included the full FT protocol, but focused on the
individual roles of magnesium oxide and ONS. This previous study
demonstrates the success of individual protocol elements.
This systematic review has its limits because of the low number
of eligible studies, most with small sample sizes. There were no
RCTs among the seven studies evaluated and all used a historical
control group. Patient care, other than the treatment being inves-
tigated, may have changed over time and thus potentially affects
the final results. There was large heterogeneity regarding outcome
measures, number of FT items and discharge criteria.
However, based on the reviewed evidence, FT programmes for
hepatopancreatic resections appear to be safe and associated with
a reduction in length of hospital stay. Drawing from previous
experience of FT implementation in colorectal surgery, further
investigation of FT vs. traditional care in hepatopancreatic surgery
is probably unnecessary. Future investigation should focus on
optimizing individual elements of the FT programme within the
context of liver and pancreatic surgery, and identifying any
procedure-specific modifications that may be needed.
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